DCRI, CVCT Launch Initiative to Advance Prevention as Clinical, Regulatory Endpoints

The Duke Clinical Research Institute (DCRI) and CardioVascular Clinical Trialists (CVCT) have announced a formal three-year partnership to establish a clear pathway to regulatory and clinical acceptance of cardiovascular prevention therapies. Titled "Pathway to Prevention," the initiative will…